M Slavík
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Surgery 12
- Esophageal Cancer Research and Treatment 3
-
- Gastric Cancer Management and Outcomes 3
- Brain Metastases and Treatment 2
- Co-authors
- Pavel Šlampa (25 shared papers)Tomáš Kazda (28 shared papers)Petr Burkoň (19 shared papers)Petr Pospíšil (10 shared papers)Tomáš Procházka (8 shared papers)Radim Jančálek (5 shared papers)Ondřej Slabý (9 shared papers)Jiří Šáňa (9 shared papers)
- Journals
- Journal of Oral Pathology and Medicine (2 papers)Radiation Oncology (2 papers)Journal of Personalized Medicine (1 paper)Disease Markers (1 paper)Biomedicines (1 paper)
- Partner nations
- CzechiaUnited StatesAustria
In The Last Decade
M Slavík
44 papers receiving 447 citations
Peers
Comparison fields: 5 of 60
- Otorhinolaryngology 35
- Genetics 84
- Cancer Research 71
- Pulmonary and Respiratory Medicine 124
- Obstetrics and Gynecology 23
Countries citing papers authored by M Slavík
This map shows the geographic impact of M Slavík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Slavík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Slavík more than expected).
Fields of papers citing papers by M Slavík
This network shows the impact of papers produced by M Slavík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Slavík. The network helps show where M Slavík may publish in the future.
Co-authors
The 25 scholars most cited alongside M Slavík, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 117 | |
| 2 | 2018 | 47 | |
| 3 | 2017 | 43 | |
| 4 | Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. | 1984 | 26 |
| 5 | 2019 | 22 | |
| 6 | 2022 | 17 | |
| 7 | 2020 | 16 | |
| 8 | 2020 | 12 | |
| 9 | 2018 | 11 | |
| 10 | Stereotactic body radiation therapy for colorectal cancer liver metastases; early results. | 2012 | 10 |
| 11 | 1986 | 10 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2018 | 8 | |
| 15 | 2019 | 8 | |
| 16 | 2020 | 7 | |
| 17 | Clinical studies with DTIC (NSC-45388) in various malignancies. | 1976 | 6 |
| 18 | 2018 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2021 | 5 |
About M Slavík
M Slavík is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Cancer Research and Epidemiology, having authored 50 papers that have together received 453 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (8 papers), Breast Cancer Treatment Studies (4 papers), Gastric Cancer Management and Outcomes (3 papers), Esophageal Cancer Research and Treatment (3 papers), Glioma Diagnosis and Treatment (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Bone fractures and treatments (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (35 citations), Genetics (84 citations), Cancer Research (71 citations), Pulmonary and Respiratory Medicine (124 citations) and Obstetrics and Gynecology (23 citations). M Slavík has collaborated with scholars based in Czechia, United States and Austria. Frequent co-authors include Pavel Šlampa, Tomáš Kazda, Petr Burkoň, Petr Pospíšil, Tomáš Procházka, Radim Jančálek, Ondřej Slabý, Jiří Šáňa, Ludmila Hynková and Nadia N. Laack. Their work appears in journals such as Journal of Oral Pathology and Medicine, Radiation Oncology, Journal of Personalized Medicine, Disease Markers and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.